Dr. Reddy's Laboratories Limited (RDY)
NYSE: RDY · Real-Time Price · USD
13.60
+0.05 (0.37%)
At close: May 22, 2026, 4:00 PM EDT
13.62
+0.02 (0.14%)
After-hours: May 22, 2026, 7:00 PM EDT

Dr. Reddy's Laboratories Income Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
337,002325,535279,164245,879214,391
Revenue Growth (YoY)
3.52%16.61%13.54%14.69%13.00%
Cost of Revenue
122,392135,107115,557106,536100,551
Gross Profit
214,610190,428163,607139,343113,840
Selling, General & Admin
146,55793,87077,20168,02662,081
Depreciation & Amortization Expenses
20,588----
Research & Development
-27,38022,87319,38117,482
Other Operating Expenses
3,5186,0514,2026,60610,323
Total Operating Expenses
170,663127,301104,27694,01389,886
Operating Income
43,94763,12759,33145,33023,954
Interest Income
13,5847,5535,7054,2813,077
Interest Expense
3,738-2,829-1,711-1,428-958
Other Non-Operating Income (Expense)
1344,9414,1413,2232,822
Total Non-Operating Income (Expense)
17,4569,6658,1356,0764,941
Pretax Income
53,92776,78471,87060,36732,298
Provision for Income Taxes
-19,53916,18615,3008,730
Net Income
41,96056,54455,68445,06723,568
Minority Interest in Earnings
-768701---
Net Income to Common
41,96056,54455,68445,06723,568
Net Income Growth
-25.79%1.54%23.56%91.22%36.72%
Shares Outstanding (Basic)
1,085833832830829
Shares Outstanding (Diluted)
1,086834834832832
Shares Change (YoY)
30.18%0.08%0.19%0.03%0.01%
EPS (Basic)
38.6867.8967.0454.2828.42
EPS (Diluted)
38.6467.7966.9254.1728.34
EPS Growth
-43.00%1.30%23.54%91.16%36.70%
Shares Outstanding
832.57832832.64830.78829.79
Free Cash Flow
33,42938,91749,07747,55213,448
Free Cash Flow Growth
-14.10%-20.70%3.21%253.60%-48.20%
Free Cash Flow Per Share
30.7846.6558.8857.1616.17
Dividends Per Share
8.0008.0008.0008.0006.000
Dividend Growth
---33.33%20.00%
Gross Margin
63.68%58.50%58.61%56.67%53.10%
Operating Margin
13.04%19.39%21.25%18.44%11.17%
Profit Margin
16.00%17.58%19.95%18.33%10.99%
FCF Margin
9.92%11.95%17.58%19.34%6.27%
EBITDA
64,55280,16474,03157,96635,778
EBITDA Margin
19.15%24.63%26.52%23.57%16.69%
EBIT
43,94763,12759,33145,33023,954
EBIT Margin
13.04%19.39%21.25%18.44%11.17%
Effective Tax Rate
0.00%25.45%22.52%25.35%27.03%
Updated May 12, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q